Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

Share Price is delayed by 15 minutes
Get Live Data
872.00    -20.00 (-2.24%)
Bid:
870.00
Ask:
884.00
Spread: 14.00 (1.609%)
Market Cap: £18.51b
AIBG Live PriceLast checked at - London Stock Exchange

Intraday Aib Group Share Chart

Stabilisation Notice

16 Oct 2023 09:32

RNS Number : 2235Q
J.P. Morgan SE
16 October 2023
 

16th October 2023

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

AIB Group plc 

Pre-stabilisation Period Announcement

J.P. Morgan SE, (contact: Marc Lewell 33140154439) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

AIB Group plc 

Guarantor (if any):

N/A

Aggregate nominal amount:

EUR benchmark

Description:

8NC7 Green HoldCo Senior

Listing: Euronext Dublin

Offer price:

TBC

Other offer terms:

?100k+?1k

Stabilisation: Relevant Stabilisation regulation applies 

Stabilisation Manager(s):

J.P. Morgan SE (Stabilisation coordinator)

BNP (Stabilisation manager)

Goodbody (Stabilisation manager)

ING (Stabilisation manager)

Natwest (Stabilisation manager)

TD securities (Stabilisation manager)

ING (Stabilisation manager)

 

Stabilisation period expected to start on:

 16th October 2023

 

Stabilisation period expected to end no later than:

16th November 2023

Existence, maximum size and conditions of use of over?allotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAVQLBFXBLXFBB
Date   Source Headline
3rd Jun 20264:17 pmRNSHolding in Company
3rd Jun 202612:46 pmRNSResult of Odd lot Offer
3rd Jun 202611:25 amRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 20267:35 amRNSHolding in Company
2nd Jun 20267:38 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSAIB Group plc - Transaction in Own Shares
27th May 20267:00 amRNSAIB Group plc - Directorate change
26th May 20267:00 amRNSHolding in Company
22nd May 20265:50 pmRNSAIB Group plc Transaction in Own Shares
21st May 20268:21 amRNSHolding in Company
18th May 20263:24 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSAIB Group plc Transaction in Own Shares
15th May 20265:14 pmRNSHolding in Company
13th May 20269:57 amRNSDirectorate change
11th May 20269:35 amRNSAIB Group plc - Transaction in Own Shares
7th May 20268:02 amRNSHolding in Company
6th May 20268:15 amRNSHolding in Company
5th May 202611:07 amRNSAIB Group plc - Transaction in Own Shares
5th May 20267:00 amRNSBlock Listing Application
1st May 20261:00 pmRNSLaunch of Odd lot Offer
1st May 20269:33 amRNSTotal Voting Rights
1st May 20268:36 amRNSHolding in Company
30th Apr 20263:39 pmRNSResult of AGM
30th Apr 202612:09 pmRNSAppointment of Deputy Chair
30th Apr 20267:00 amRNSAIB Group plc Q1 2026 Trading Statement
27th Apr 20267:00 amRNSAIB Group plc - Transaction in Own Shares
20th Apr 20267:00 amRNSAIB Group plc -Transaction in Own Shares
13th Apr 20269:52 amRNSAIB Group plc - Transaction in own shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:05 amRNSTotal Voting Rights
30th Mar 20263:00 pmRNSNotice of AGM
30th Mar 20267:00 amRNSAIB Group plc - Transaction in Own Shares
26th Mar 20267:00 amRNSDirectorate change
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
19th Mar 20264:21 pmRNSHolding in Company
19th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
18th Mar 202610:31 amRNSHolding in Company
18th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
17th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
17th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
16th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
16th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
13th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
13th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
12th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
11th Mar 20267:00 amRNSAIB Group plc Transaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20263:16 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.